Showing 121-130 of 350 grants

Title Institution Researcher Program Duration Total Award Amount
A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation The University of Chicago Piotr Witkowski Cures 01-February-2025 to 31-January-2027 $1.500.000,00
Safety and efficacy assessment of Tegoprubart and calcineurin inhibitors- free immunosuppression therapy for pancreatic islet transplantation in patients with t1DM and chronic kidney disease. The University of Chicago Piotr Witkowski Cures 01-September-2025 to 31-August-2029 $8.500.000,00
MDA5 and TRIM21 in β-cell inflammatory signaling and autoimmunity The University of Chicago Kerim Kaylan Cures 01-July-2026 to 30-June-2028 $100.000,00
Development of β-Cell Targeted Lipid Nanoparticle Therapeutics The University of Chicago Jacob Ryan Enriquez Cures 01-March-2025 to 29-February-2028 $247.790,00
Interferons and the Integrated Stress Response: Converging Pathways in β Cell Dysfunction in Type 1 Diabetes The University of Chicago Charanya Muralidharan Cures 01-March-2026 to 28-February-2029 $95.000,00
Dissecting HLA Mechanisms in T1D, SLE, and MS Through High-Throughput Self-Antigen Profiling The University of Chicago Aly Khan Cures 01-September-2025 to 31-August-2026 $150.000,00
Project Tuyinza The Sonia Nabeta Foundation Vivian Nabeta Mission 01-April-2026 to 31-March-2029 $643.550,00
Quality, Equity & Outcomes Program The Sonia Nabeta Foundation Vivian Nabeta Mission 01-September-2026 to 31-August-2028 $1.400.000,00
Triple therapy for T1DM with insulin, semaglutide and dapagliflozin The Research Foundation of SUNY on behalf of University at Buffalo Paresh Dandona Improving Lives 01-January-2019 to 31-December-2026 $1.808.522,70
Prediction of Cancer Immunotherapy Precipitated Autoimmune Diabetes The Regents of the University of California, San Francisco Zoe Quandt Cures 01-March-2025 to 28-February-2030 $1.000.000,00